Beranda › Disfungsi Ventrikel Kiri › New York
Uji klinis Disfungsi Ventrikel Kiri di New York
4 studi untuk Disfungsi Ventrikel Kiri mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Columbia University Medical Center-Pediatric Cardiology ( Site 0016), New York
- The Children's Hospital at Montefiore ( Site 0030), The Bronx
Menerima pesertaFase 2/3
29 Days – 17 Years · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Menerima pesertaFase 3
Hingga usia 18 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Menerima pesertaFase 3
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT07188805AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT06699056Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.